Sign inJoin waitlistJoin the waitlist

SK

Swetha Kambhampati

Physician · City of Hope

Credentials: · · · ·

History

City of Hope
2022–Present

Hematology and Medical Oncology
University of California (San Francisco) School of Medicine
2017–2019
Internal Medicine
2014–2017
Stanford University School of Medicine
2010–2014

Research

Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy
Blood Advances · 2022 · First of 11 authors · Corresponding · 116 citations
Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for…
Transplantation and Cellular Therapy · 2024 · 89 citations
Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series
Cancer · 2019 · First of 7 authors · 88 citations

AH
Alex Herrera
22 papers
MM
Matthew Mei
11 papers
Elizabeth Budde
9 papers
AD
Alexey Danilov
7 papers
Leslie Popplewell
7 papers
LK
Larry Kwak
6 papers
Stephen Forman
6 papers
Steven Rosen
6 papers
Geoffrey Shouse
5 papers
Liana Nikolaenko
5 papers
NS
Nina Shah
5 papers
SW
Sandy Wong
5 papers

Clinical trials

Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
Principal investigator · Suspended · Phase 2
City of Hope Medical Center
2025–2028
Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma
Principal investigator · Active not recruiting · Phase 2
City of Hope Medical Center
2024–2027
Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Principal investigator · Recruiting · Phase 2
City of Hope Medical Center
2024–2027